Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aditxt, Inc. stock logo
ADTX
Aditxt
$0.06
-5.4%		$24.27
$0.06
▼
$1,979.67
$57K1.084.89 million shs24.66 million shs
GRI Bio, Inc. stock logo
GRI
GRI Bio
$2.03
-5.6%		$2.42
$2.03
▼
$80.36
$3.59M-1.2241,390 shs21,569 shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.58
-1.3%		$1.85
$1.25
▼
$1,046.99
$1.52M1.9622,878 shs5,532 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aditxt, Inc. stock logo
ADTX
Aditxt
-96.30%-98.03%-99.46%-99.95%-100.00%
GRI Bio, Inc. stock logo
GRI
GRI Bio
0.00%-8.76%-18.47%-12.12%-95.07%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00%-5.16%-17.75%-39.46%-99.37%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aditxt, Inc. stock logo
ADTX
Aditxt
$0.06
-5.4%		$24.27
$0.06
▼
$1,979.67
$57K1.084.89 million shs24.66 million shs
GRI Bio, Inc. stock logo
GRI
GRI Bio
$2.03
-5.6%		$2.42
$2.03
▼
$80.36
$3.59M-1.2241,390 shs21,569 shs
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.58
-1.3%		$1.85
$1.25
▼
$1,046.99
$1.52M1.9622,878 shs5,532 shs
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google

Looking for the next FAANG stock before everyone has heard about it? Click the link to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aditxt, Inc. stock logo
ADTX
Aditxt
-96.30%-98.03%-99.46%-99.95%-100.00%
GRI Bio, Inc. stock logo
GRI
GRI Bio
0.00%-8.76%-18.47%-12.12%-95.07%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
0.00%-5.16%-17.75%-39.46%-99.37%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aditxt, Inc. stock logo
ADTX
Aditxt
1.00
SellN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
2.33
Hold$1,008.0049,555.17% Upside
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
1.00
SellN/AN/A

Current Analyst Ratings Breakdown

Latest GRI, ADTX, and SXTC Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/1/2026
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E) ➝ Sell (E+)
4/21/2026
GRI Bio, Inc. stock logo
GRI
GRI Bio
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
4/20/2026
Aditxt, Inc. stock logo
ADTX
Aditxt
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
(Data available from 5/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aditxt, Inc. stock logo
ADTX
Aditxt
$3.20K17.88N/AN/A$9.61 per share0.01
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/A$5.95 per shareN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
$1.54M0.99N/AN/A$3,187.45 per share0.00
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aditxt, Inc. stock logo
ADTX
Aditxt
-$41.71M-$11,103.38N/AN/AN/A-1,217,927.00%-374.60%-92.82%6/3/2026 (Estimated)
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$11.96M-$235.02N/AN/AN/AN/A-199.52%-143.23%5/21/2026 (Estimated)
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
-$3.30MN/AN/AN/AN/AN/AN/AN/AN/A

Latest GRI, ADTX, and SXTC Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
6/3/2026N/A
Aditxt, Inc. stock logo
ADTX
Aditxt
-$8,316,800,000.00N/AN/AN/A$1.00 millionN/A
5/21/2026Q1 2026
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$3.74N/AN/AN/AN/AN/A
5/13/2026Q1 2026
GRI Bio, Inc. stock logo
GRI
GRI Bio
-$1.6050-$1.61-$0.0050-$1.61N/AN/A
3/31/2026Q4 2025
Aditxt, Inc. stock logo
ADTX
Aditxt
N/A$315,563.31N/A$11,687.50N/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aditxt, Inc. stock logo
ADTX
Aditxt
N/AN/AN/AN/AN/A
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/AN/AN/AN/AN/A
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aditxt, Inc. stock logo
ADTX
Aditxt
N/A
0.31
0.31
GRI Bio, Inc. stock logo
GRI
GRI Bio
N/A
14.20
3.25
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
N/A
4.37
4.24

Institutional Ownership

CompanyInstitutional Ownership
Aditxt, Inc. stock logo
ADTX
Aditxt
15.54%
GRI Bio, Inc. stock logo
GRI
GRI Bio
33.95%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
5.02%

Insider Ownership

CompanyInsider Ownership
Aditxt, Inc. stock logo
ADTX
Aditxt
0.01%
GRI Bio, Inc. stock logo
GRI
GRI Bio
8.73%
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
3.95%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aditxt, Inc. stock logo
ADTX
Aditxt
60904,000904,000No Data
GRI Bio, Inc. stock logo
GRI
GRI Bio
11.77 million1.62 millionNot Optionable
China SXT Pharmaceuticals, Inc. stock logo
SXTC
China SXT Pharmaceuticals
90963,000925,000Not Optionable

Recent News About These Companies

China SXT Pharmaceuticals Raises $3.5 Million in Offshore Private Placement
May 11, 2026  |  theglobeandmail.comhttps://www.theglobeandmail.com/investing/markets/stocks/SXTC/pressreleases/1725271/china-sxt-pharmaceuticals-raises-35-million-in-offshore-private-placement/
China Sxt Pharmaceuticals, Inc. Class A
April 7, 2026  |  edition.cnn.comhttps://edition.cnn.com/markets/stocks/SXTC
China SXT Pharmaceuticals, Inc. Announces Share Re-classification
March 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/03/23/3260426/0/en/china-sxt-pharmaceuticals-inc-announces-share-re-classification.html
This nano-cap pharma stock crashed 30% today – what triggered the sell-off?
January 30, 2026  |  msn.comhttps://www.msn.com/en-us/money/topstocks/this-nano-cap-pharma-stock-crashed-30-today-what-triggered-the-sell-off/ar-AA1Vlre8
China SXT Pharmaceuticals, Inc. Announces Share Consolidation
January 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/30/3229570/0/en/china-sxt-pharmaceuticals-inc-announces-share-consolidation.html
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC INITIATIVE TO APPLY AI TECHNOLOGY ACROSS THE TCM SUPPLY CHAIN
January 15, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/news/china-sxt-pharmaceuticals-inc-announces-140000189.html
Univest Securities, LLC Announces Closing of $10 Million Registered Direct Offering for its Client China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC)
January 13, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/13/3218322/0/en/univest-securities-llc-announces-closing-of-10-million-registered-direct-offering-for-its-client-china-sxt-pharmaceuticals-inc-nasdaq-sxtc.html
Why China SXT Pharmaceuticals, Inc.’s (SXTC) Stock Is Down 8.81%
January 11, 2026  |  aaii.comA
China SXT Pharmaceuticals Inc. Announces $10 Million Registered Direct Offering
January 9, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/01/09/3216306/0/en/china-sxt-pharmaceuticals-inc-announces-10-million-registered-direct-offering.html
CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND ...
January 8, 2026  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/china-sxt-pharmaceuticals-inc-announces-strategic-ai-insights-initiative-to-optimize-traditional-chinese-medicine-portfolio-enhance-market-analysis-and-explore-ai-supported-clinic-deployment-1035694618
Why China SXT Pharmaceuticals, Inc.’s (SXTC) Stock Is Up 6.88%
January 3, 2026  |  aaii.comA
China SXT Pharmaceuticals Full Year 2025 Earnings: US$2.32 loss per share (vs US$28.58 loss in FY 2024)
August 2, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/china-sxt-pharmaceuticals-full-2025-135509995.html
China SXT Pharmaceuticals Inc. (SXTC) Stock Price Today - WSJ
July 30, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/SXTC
China SXT Pharmaceuticals, Inc. (SXTC) - Yahoo Finance
July 4, 2025  |  sg.finance.yahoo.comhttps://sg.finance.yahoo.com/quote/SXTC/news/
China SXT Pharmaceuticals Inc News (SXTC) - Investing.com
June 25, 2025  |  investing.comhttps://www.investing.com/equities/china-sxt-pharma-news
China SXT Pharmaceuticals Issues 90 Million Shares Following Warrant Exercise
June 16, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-issues-90-million-shares-following-warrant-exercise?utm_source=marketbeat.com&utm_medium=referral
China SXT Pharmaceuticals Inc Ordinary Shares
April 23, 2025  |  morningstar.comM
China SXT Pharmaceuticals Reports Financial Results Amid Regulatory Challenges
March 28, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-reports-financial-results-amid-regulatory-challenges?utm_source=marketbeat.com&utm_medium=referral
China SXT Pharmaceuticals Optimizes Capital Structure with Warrant Exchange
March 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/china-sxt-pharmaceuticals-optimizes-capital-structure-with-warrant-exchange?utm_source=marketbeat.com&utm_medium=referral
China SXT Pharmaceuticals regains compliance with Nasdaq
March 17, 2025  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/china-sxt-pharmaceuticals-regains-compliance-with-nasdaq-1034483842

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Valmont Industries logo overlaid on a field scene featuring a center-pivot irrigation system and utility infrastructure.
1 Stock Is Powering the AI Boom and the Next Farm Supercycle
By Jeffrey Neal Johnson | April 22, 2026
Satellite night view of North America overlaid with financial charts and bar graphs.
The USMCA Review Is Coming: 3 Border-Sensitive Stocks to Watch
By Chris Markoch | May 8, 2026
An Astera Labs branded semiconductor chip sits on a circuit board with glowing blue data lines.
Astera Labs: The Tollbooth for AI's Traffic Jam
By Jeffrey Neal Johnson | April 23, 2026
A Chipotle Mexican Grill burrito bowl, foil-wrapped burrito, and branded drink cup on a restaurant table.
Chipotle Stock Just Hit Bottom—Is a Breakout Next?
By Thomas Hughes | April 30, 2026
A green and white combine harvester operates in a golden wheat field under a clear blue sky.
3 Agriculture Stocks to Buy as Food Inflation Stays Elevated in 2026
By Chris Markoch | April 20, 2026
Aditxt stock logo

Aditxt NASDAQ:ADTX

$0.06 0.00 (-5.39%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$0.06 -0.01 (-11.23%)
As of 05/15/2026 07:49 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Aditxt, Inc., a biotech company, engages in the development and commercialization of technologies that focus on improving the health through monitoring and modulating the immune systems. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its tissues. It also develops ADI-100 for skin grafting, psoriasis, type 1 diabetes, and multiple sclerosis. Aditxt, Inc. has a license agreement with Loma Linda University and Leland Stanford Junior University. The company was formerly known as ADiTx Therapeutics, Inc. and changed its name to Aditxt, Inc. in July 2021. Aditxt, Inc. was incorporated in 2017 and is headquartered in Richmond, Virginia.

GRI Bio stock logo

GRI Bio NASDAQ:GRI

$2.03 -0.12 (-5.58%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$2.07 +0.04 (+1.87%)
As of 05/15/2026 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

China SXT Pharmaceuticals stock logo

China SXT Pharmaceuticals NASDAQ:SXTC

$1.58 -0.02 (-1.25%)
Closing price 05/15/2026 04:00 PM Eastern
Extended Trading
$1.54 -0.04 (-2.41%)
As of 05/15/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals in 10 provinces and municipalities in China. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas